Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Corbus Pharmaceuticals Holdings (CRBP) Equity Ratio (2016 - 2025)

Corbus Pharmaceuticals Holdings has reported Equity Ratio over the past 10 years, most recently at 0.24 for Q4 2023.

  • For Q4 2023, Equity Ratio fell 149.09% year-over-year to 0.24; the TTM value through Dec 2023 reached 0.24, down 149.09%, while the annual FY2023 figure was 0.24, 149.09% down from the prior year.
  • Equity Ratio for Q4 2023 was 0.24 at Corbus Pharmaceuticals Holdings, down from 0.01 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.65 in Q1 2021 and troughed at 0.24 in Q4 2023.
  • A 5-year average of 0.42 and a median of 0.47 in 2020 define the central range for Equity Ratio.
  • Biggest five-year swings in Equity Ratio: surged 253.23% in 2020 and later plummeted 149.09% in 2023.
  • Year by year, Equity Ratio stood at 0.13 in 2019, then soared by 253.23% to 0.44 in 2020, then skyrocketed by 44.94% to 0.64 in 2021, then dropped by 22.45% to 0.5 in 2022, then plummeted by 149.09% to 0.24 in 2023.
  • Business Quant data shows Equity Ratio for CRBP at 0.24 in Q4 2023, 0.01 in Q3 2023, and 0.22 in Q2 2023.